Given that endothelial P2Y1-R activity contributes NO-dependent vasorelaxation in mice and endothelial cell proliferation and migration [8,33,34] (Figure 1 and Figure 2), P2Y12-R antagonists treatment might favor endothelial dysfunction and hypertension. This evidence concerns the gene P2RY12 and endothelial dysfunction.